Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

MLA

Tsou, Pei‐Suen, and Amr H. Sawalha. “Glycoprotein Nonmetastatic Melanoma Protein B: A Key Mediator and an Emerging Therapeutic Target in Autoimmune Diseases.” FASEB Journal, vol. 34, no. 7, July 2020, pp. 8810–23. EBSCOhost, https://doi.org/10.1096/fj.202000651.

APA

Tsou, P., & Sawalha, A. H. (2020). Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases. FASEB Journal, 34(7), 8810–8823. https://doi.org/10.1096/fj.202000651

Chicago

Tsou, Pei‐Suen, and Amr H. Sawalha. 2020. “Glycoprotein Nonmetastatic Melanoma Protein B: A Key Mediator and an Emerging Therapeutic Target in Autoimmune Diseases.” FASEB Journal 34 (7): 8810–23. doi:10.1096/fj.202000651.